1. Home
  2. FMNB vs DRUG Comparison

FMNB vs DRUG Comparison

Compare FMNB & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmers National Banc Corp.

FMNB

Farmers National Banc Corp.

HOLD

Current Price

$15.34

Market Cap

884.6M

Sector

Finance

ML Signal

HOLD

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$49.90

Market Cap

778.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FMNB
DRUG
Founded
1887
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
884.6M
778.4M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
FMNB
DRUG
Price
$15.34
$49.90
Analyst Decision
Buy
Strong Buy
Analyst Count
3
9
Target Price
$17.00
★ $152.40
AVG Volume (30 Days)
★ 291.4K
130.4K
Earning Date
11-03-2026
08-17-2026
Dividend Yield
★ 4.65%
N/A
EPS Growth
★ 18.85
N/A
EPS
★ 0.76
N/A
Revenue
★ $279,922,000.00
N/A
Revenue This Year
$39.49
N/A
Revenue Next Year
$7.45
N/A
P/E Ratio
$20.39
★ N/A
Revenue Growth
★ 3.89
N/A
52 Week Low
$12.23
$47.23
52 Week High
$16.46
$123.75

Technical Indicators

Market Signals
Indicator
FMNB
DRUG
Relative Strength Index (RSI) 50.59 40.14
Support Level $14.80 $47.23
Resistance Level $15.43 $55.78
Average True Range (ATR) 0.25 3.86
MACD 0.04 0.86
Stochastic Oscillator 64.29 25.48

Price Performance

Historical Comparison
FMNB
DRUG

About FMNB Farmers National Banc Corp.

Farmers National Banc Corp is a financial holding company based in the U.S. Along with its subsidiaries, it operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The group offers a full range of commercial and retail banking services, including checking accounts, savings accounts, time deposit accounts, commercial, mortgage, and installment loans, safe deposit boxes, ATMs, internet banking, and other banking services. Additionally, it offers personal and corporate trust services in the areas of estate settlement, trust administration, employee benefit plans, and retirement services; insurance products, and other financial products and services. The group's reportable segments are Bank, which generates the maximum revenue, and Trust.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: